Referenser för Angemin
Författare, artikel och publikation |
År
|
Hämta abstract / fulltext
|
|
1. Skouby SO. The rationale for a wider range of progestogens.
Climacteric. December; 3 (Suppl.2):12-20, 2000. |
2000 |
Hämta här |
|
2. Schneider HP. Androgens and Antiandrogens.
Ann N Y Acad Sci. Nov; 997:292-306, 2003. |
2003 |
Hämta här |
|
3. Rubig A. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
Climacteric, October; 6 (Suppl. 3):49-54, 2003. |
2003 |
Hämta här |
|
4. Gaspard U, Van den Brule F:
Angeliq: new hormonal therapy of the menopaus, with antialdosterone and antiandrogenic properties.
Rev Med Liege 59(3):162-6; 2004. |
2004 |
Hämta här |
|
5. Kaunitz AM:
Enhancing oral contraceptive success: the potential of new formulations.
Am J Obstet Gynecol 190(4 Suppl):23-9; 2004. |
2004 |
Hämta här |
6. Oelkers W:
Drospirenone, a progestogen with antimineralcorticoid properties: a short review.
Mol Cell Endocrinol 217(1-2):255-61; 2004. |
2004 |
Hämta här |
7. Sitruk-Ware RL:
Hormone therapy and the cardivascular system: the critical role of progestins.
Climacteric 6:(Suppl 3), 21-8; 2003. |
2003 |
Hämta här |
8. Sitruk-Ware, RL:
Pharmacological profile of progestins.
Maturitas 47(4):277-83; 2004. |
2004 |
Hämta här |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
